|
Moving
to China
Every other MNC pharma company is setting up R&D operations
in China. The Chinese Government is also determined to attract
big pharma. The controversy over the patent law in India has
only added to the phenomenon. However, the move to China can
be attributed to various reasons. Sushmi Dey explores
Bayer's
launches new glucose monitor
Bayer Diabetes Care, a division of Bayer HealthCare announced
the introduction of the new Contour TS blood glucose monitoring
system.
NPIL
hives off R&D unit
Nicholas Piramal has de-merged its NCE research unit into
a separate company.
Caraco
to market generic version of Zyloprim
Caraco Pharmaceutical Laboratories announced that USFDA has
granted final approval for the Company's ANDA for Allopurinol
Tablets USP, 100 mg and 300 mg (Allopurinol).
Elder
to acquire stake in Bulgarian co
Elder Pharmaceutical has announced the acquisition of Biomeda
Group in Bulgaria.
CDRI
licenses novel anti-malarial compound to Ipca
Central Drug Research Institute (CDRI) has entered into a
collaborative-cum-license agreement with Ipca for further
development of its compound 99/411, a promising synthetic
substitute for drugs based on Artemisinin derived from the
plant Artemisia annua.
Bharat
Biotech launches BioHib
Bharat Biotech International Limited (BBIL) announced the
launch of BioHib, the first indigenously developed and manufactured
Haemophilus Influenza type b (Hib) vaccine in India.
Zydus
Cadila files fifth IND
Zydus Cadila has filed yet another IND (Investigational New
Drug) application for seeking DCGI's permission for conducting
clinical trials for its New Molecular Entity (NME) - ZYH7,
a novel drug candidate for treating dyslipidemia and metabolic
disorders.
Dr
Reddy's launches Ebernet
Ebernet (Eberconazole 1 percent cream) has been launched nationwide
in September, marking the entry of Dr. Reddy's into the Rs
100 crore topical anti-fungal market, with an innovative,
first to launch formulation.
From
bugs to drugs
Though they were viewed with scepticism earlier, probiotics
are slowly making their way into conventional medicine. Kanwaldeep
Chadha, Country Manager, CD Pharma, India and Director Asia
Pacific, VSL Pharmaceuticals speaks to Arshiya Khan, on the
company's strategies for tapping the probiotics market in
India
Events
When
pathologists meet
The 26th quarterly meeting and scientific session of the Association
of Practising Pathologists was held recently in Delhi.
We
will bring all our B2B events to India
The top officials of CMP Information were in Mumbai for the
preparation of CPhI India 2007 expo to be held at Bombay Exhibition
Centre, Mumbai between November 25 and 27. Express Pharma
had a brief chat with the team including Annemieke Timmers,
Events Director - CPhI Worldwide; Eliane van Droom - Group
Director, Pharma Portfolio; and Hans Stoter, Event Manager
- ICSE & P-MEC.
A
clinician's perspective
A two- day conference conducted by International Business
Conferences (IBC) saw researchers in full swing discussing
and debating issues close to their profession. Garima Arora
reports
Upcoming
Events
|
